
Alexander J. Yi
Examiner (ID: 13085, Phone: (571)270-7696 , Office: P/2641 )
| Most Active Art Unit | 2643 |
| Art Unit(s) | 2641, 2617, 2643 |
| Total Applications | 522 |
| Issued Applications | 341 |
| Pending Applications | 40 |
| Abandoned Applications | 151 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4960045
[patent_doc_number] => 20080274470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'NON-INVASIVE DETECTION OF ENDOMETRIAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/114584
[patent_app_country] => US
[patent_app_date] => 2008-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3897
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274470.pdf
[firstpage_image] =>[orig_patent_app_number] => 12114584
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/114584 | NON-INVASIVE DETECTION OF ENDOMETRIAL CANCER | May 1, 2008 | Abandoned |
Array
(
[id] => 5289925
[patent_doc_number] => 20090022655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Nanotubes for Cancer Therapy and Diagnostics'
[patent_app_type] => utility
[patent_app_number] => 12/112986
[patent_app_country] => US
[patent_app_date] => 2008-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10810
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022655.pdf
[firstpage_image] =>[orig_patent_app_number] => 12112986
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/112986 | Nanotubes for cancer therapy and diagnostics | Apr 29, 2008 | Issued |
Array
(
[id] => 4739476
[patent_doc_number] => 20080233129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Ligand that has binding specificity for IL-4 and/or lL-13'
[patent_app_type] => utility
[patent_app_number] => 12/150487
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 50160
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233129.pdf
[firstpage_image] =>[orig_patent_app_number] => 12150487
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150487 | Ligand that has binding specificity for IL-4 and/or lL-13 | Apr 28, 2008 | Abandoned |
Array
(
[id] => 4739477
[patent_doc_number] => 20080233130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Ligand that has binding specificity for IL-4 and/or IL-13'
[patent_app_type] => utility
[patent_app_number] => 12/150567
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 50095
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12150567
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150567 | Ligand that has binding specificity for IL-4 and/or IL-13 | Apr 28, 2008 | Abandoned |
Array
(
[id] => 5322874
[patent_doc_number] => 20090060864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies'
[patent_app_type] => utility
[patent_app_number] => 12/148629
[patent_app_country] => US
[patent_app_date] => 2008-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13764
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20090060864.pdf
[firstpage_image] =>[orig_patent_app_number] => 12148629
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/148629 | Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies | Apr 20, 2008 | Issued |
Array
(
[id] => 5458226
[patent_doc_number] => 20090258378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'STRESS-INDUCED PHOSPHOPROTEIN 1 AS A BIOMARKER FOR THE DETECTION OF HUMAN OVARIAN CANCERS AND ENDOMETRIOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/102807
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8355
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258378.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102807 | Stress-induced phosphoprotein 1 as a biomarker for the detection of human ovarian cancers and endometriosis | Apr 13, 2008 | Issued |
Array
(
[id] => 177700
[patent_doc_number] => 07655408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'PCA3 messenger RNA species in benign and malignant prostate tissues'
[patent_app_type] => utility
[patent_app_number] => 12/098577
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 13313
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655408.pdf
[firstpage_image] =>[orig_patent_app_number] => 12098577
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/098577 | PCA3 messenger RNA species in benign and malignant prostate tissues | Apr 6, 2008 | Issued |
Array
(
[id] => 4683161
[patent_doc_number] => 20080249387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Enhanced monitor compliance'
[patent_app_type] => utility
[patent_app_number] => 12/080318
[patent_app_country] => US
[patent_app_date] => 2008-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4097
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249387.pdf
[firstpage_image] =>[orig_patent_app_number] => 12080318
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/080318 | Enhanced monitor compliance | Apr 1, 2008 | Abandoned |
Array
(
[id] => 4561088
[patent_doc_number] => 07846447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction'
[patent_app_type] => utility
[patent_app_number] => 12/077508
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7461
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/846/07846447.pdf
[firstpage_image] =>[orig_patent_app_number] => 12077508
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/077508 | Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction | Mar 18, 2008 | Issued |
Array
(
[id] => 4727235
[patent_doc_number] => 20080206777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/072651
[patent_app_country] => US
[patent_app_date] => 2008-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11130
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206777.pdf
[firstpage_image] =>[orig_patent_app_number] => 12072651
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/072651 | Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors | Feb 26, 2008 | Abandoned |
Array
(
[id] => 4718542
[patent_doc_number] => 20080241064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN'
[patent_app_type] => utility
[patent_app_number] => 12/036875
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26583
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241064.pdf
[firstpage_image] =>[orig_patent_app_number] => 12036875
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036875 | COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN | Feb 24, 2008 | Abandoned |
Array
(
[id] => 4676152
[patent_doc_number] => 20080213782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'SOCS-1 Gene Methylation in Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/036182
[patent_app_country] => US
[patent_app_date] => 2008-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29224
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213782.pdf
[firstpage_image] =>[orig_patent_app_number] => 12036182
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/036182 | SOCS-1 gene methylation in cancer | Feb 21, 2008 | Issued |
Array
(
[id] => 196334
[patent_doc_number] => 07635759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-22
[patent_title] => 'Gene encoding labyrinthin, a marker for cancer'
[patent_app_type] => utility
[patent_app_number] => 12/029113
[patent_app_country] => US
[patent_app_date] => 2008-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8291
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/635/07635759.pdf
[firstpage_image] =>[orig_patent_app_number] => 12029113
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/029113 | Gene encoding labyrinthin, a marker for cancer | Feb 10, 2008 | Issued |
Array
(
[id] => 132307
[patent_doc_number] => 07695915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => 'Molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/012530
[patent_app_country] => US
[patent_app_date] => 2008-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 27980
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/695/07695915.pdf
[firstpage_image] =>[orig_patent_app_number] => 12012530
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/012530 | Molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof | Jan 30, 2008 | Issued |
Array
(
[id] => 6374570
[patent_doc_number] => 20100081153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'CANCER ASSOCIATED PROTEIN KINASES AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 12/018110
[patent_app_country] => US
[patent_app_date] => 2008-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24062
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081153.pdf
[firstpage_image] =>[orig_patent_app_number] => 12018110
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/018110 | CANCER ASSOCIATED PROTEIN KINASES AND THEIR USES | Jan 21, 2008 | Abandoned |
Array
(
[id] => 4739464
[patent_doc_number] => 20080233117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'REDUCING TUMOR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 12/016062
[patent_app_country] => US
[patent_app_date] => 2008-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7616
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233117.pdf
[firstpage_image] =>[orig_patent_app_number] => 12016062
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/016062 | REDUCING TUMOR GROWTH | Jan 16, 2008 | Abandoned |
Array
(
[id] => 5545371
[patent_doc_number] => 20090155248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Antibodies to MT-SP1 serine protease'
[patent_app_type] => utility
[patent_app_number] => 12/014067
[patent_app_country] => US
[patent_app_date] => 2008-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 36417
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155248.pdf
[firstpage_image] =>[orig_patent_app_number] => 12014067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/014067 | Antibodies to MT-SP1 serine protease | Jan 13, 2008 | Abandoned |
Array
(
[id] => 4681807
[patent_doc_number] => 20080248033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors'
[patent_app_type] => utility
[patent_app_number] => 12/002605
[patent_app_country] => US
[patent_app_date] => 2007-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 46398
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12002605
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/002605 | VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors | Dec 17, 2007 | Abandoned |
Array
(
[id] => 6580520
[patent_doc_number] => 20100129791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product'
[patent_app_type] => utility
[patent_app_number] => 11/956680
[patent_app_country] => US
[patent_app_date] => 2007-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 22689
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129791.pdf
[firstpage_image] =>[orig_patent_app_number] => 11956680
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/956680 | cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product | Dec 13, 2007 | Abandoned |
Array
(
[id] => 4751951
[patent_doc_number] => 20080160024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'INHIBITION OF CANCER METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 11/952198
[patent_app_country] => US
[patent_app_date] => 2007-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8023
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20080160024.pdf
[firstpage_image] =>[orig_patent_app_number] => 11952198
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/952198 | INHIBITION OF CANCER METASTASIS | Dec 6, 2007 | Abandoned |